FTSE 100 closes at five-month high
And finally... Britain’s stock market has closed at a new five-month high tonight.
Vaccine optimism continues to lift stocks, despite Christine Lagarde’s cautious words - and concerns that the UK and eurozone economies will suffer from their current lockdowns.
With investors continue to pile into shares, the FTSE 100 has closed 85 points up today at 6,382.
That’s its eighth daily rise in a row, having rallied sharply since last Monday - the start of the US election week.
This week alone, the Footsie has gained a sizzling 8%, lifted first by Joe Biden’s victory and then the news that Pfizer/BioNTech’s Covid-19 vaccine was proving 90% effective in trials.
Goldman Sachs’ prediction that the FTSE will rally to 7200 points by the end of next year (13% higher than today) gave investors another reason to be bullish.
Airline group IAG ended the day at the top riser, up 8%, with warehouse operator Segro up 6.7%.
Online grocery business Ocado was back in demand too, up 6.3%, as was DIY group Kingfisher and takeaway firm Just Eat.
But, some of this week’s star performers did fall back, as traders tried to calculate the impact of a vaccine rollout on the economy. Rolls-Royce dropped 8% (having surged by a staggering 44% on Monday).
SSP, which runs cafes and sandwich bars at transport hubs, dipped by 3% on the smaller FTSE 250 where cruise operator Carnival lost 2.6% [they both rallied hard earlier this week].
The pound did also fall back against the US dollar, losing over half a cent to $1.32, which props up multinational share prices.
Fawad Razaqzada, analyst with ThinkMarkets, says the London stock market has staged one of its sharpest 3-day rallies in years, on vaccine optimism.
The UK index, which had underperformed global and US indices badly since the initial round of lockdowns earlier in the year, has benefited from rotation into value stocks and away from growth and stay-at-home tech plays that had lifted the Nasdaq to repeated all-time highs.
Monday’s announcement from Pfizer on the progress made in coronavirus vaccine seems to have been a game changer, even if experts warn that production and distribution may take time. With ongoing central bank and government stimulus providing support, economic recovery could rebound strongly if things go back to normal next year. That’s what the markets are pricing in right now, and ignoring the current economic situation, as a result of the lockdowns and the pandemic.
While the FTSE may look a little bit stretched now, it still has a lot of ground to make up on the upside. The path of least resistance is clearly to the upside after it formed a higher high above 6040 on Monday. Now almost 400 points higher, it looks like the bulls will want to target the summer highs circa 6510 and beyond:
European markets also ended higher, with the Stoxx 600 at a new eight-month high at the close.
On New York, the Nasdaq is still leading the way - up 1.6% as tech stocks recover some of this week’s losses, while the Dow is slightly higher.
On that note, goodnight. GW
Updated
European Central Bank President Christine Lagarde had some cautious words about the pandemic today.
Lagarde told the ECB Forum on Central Banking that the eurozone may not experience a ‘linear’ recovery, despite the optimism about Pfizer’s vaccine. There would probably be bumps on the way, depending how fast treatments are rolled out.
Lagarde explained (via CNBC) that:
“While the latest news on a vaccine looks encouraging, we could still face recurring cycles of accelerating viral spread and tightening restrictions until widespread immunity is achieved.
“So the recovery may not be linear, but rather unsteady, stop-start and contingent on the pace of vaccine rollout,”
Britain has passed another dark milestone in the pandemic tonight, with the UK’s headline Covid death toll passing 50,000.
My colleague Andrew Sparrow has the details:
- The UK has recorded 595 further coronavirus deaths, taking the official headline death toll above 50,000 for the first time. This is the highest daily total since early May, and substantially above yesterday’s total - 532 - which was the previous highest total for this wave of the pandemic. The headline death total is now 50,365, making the UK the first country in Europe to pass this milestone. But this figure only counts people who have died within 28 days of testing positive for coronavirus. Taking into account all deaths where coronavirus was mentioned on the death certificate, the UK total has passed 65,000.
- There have been 2,623 deaths in the past week, up 27% on the previous week.
- The UK has recorded 22,950 further positive cases.
Tate & Lyle Sugars, a prominent corporate backer of Brexit, has warned of sugar and syrup shortages in Northern Ireland in the new year, due to lack of clarity over the UK and EU trade relationship.
The company is the largest cane sugar brand in the UK and supplies the main supermarkets in Northern Ireland. It has advised retailers to draw up contingency plans to source sugar and syrup from elsewhere, because it will struggle to get its products to them next year, according to ITV News.
Tate & Lyle Sugars, which was sold by Tate & Lyle plc to American Sugar Refining in 2010, said the uncertainty over Brexit and the Northern Ireland protocol was likely to cause significant outages in Northern Ireland. The company owns the Thames Refinery in London, the biggest sugar refinery in Europe.
Drinks giant Diageo has suffered a bitter blow today --recalling all its new non-alcoholic Guinness stout because of “microbiological contamination”.
It warned that cans of the new Guinness 0.0 drink, which took four years to develop and launched two weeks ago, may be “unsafe to consume”. If you’re got some, return it to your retailer for a refund.
The contamination is understood to have occurred during the production process at its St James’s Gate brewery in Dublin, so production and canning are on hold while tests are carried out.
With the lockdown hitting pub sales this year, this is unfortunate timing for Diageo.
Sarah Riding, partner at law firm Gowling WLG, says:
“Supply chain forethought and contingencies are key to making any product launch seamless and successful, and sometimes, it is only instances such as this that trigger a through and rigorous audit of the individual checks in place to ensure prevention at all times.
“The cost of recalling, as well as any lost brand equity can be extremely disabling at the best of times, but the pressures of the pandemic may make this even harder to bear – better guaranteeing this won’t happen in future will save far more in the long run, of course.”
Britain’s FTSE 100 is firmly on track for its eighth day of gains in a row, now up 85 points 0r 1.35% at 6383 in late trading.
Connor Campbell of SpreadEx says London’s market is leading the way today:
Less electric than the last few sessions, the markets nevertheless continued to ride the wave of Pfizer vaccine positivity.
The FTSE was head and shoulders above its peers this Wednesday. Climbing more than 1.3%, the UK index crossed 6,380 for the first time in 5-months. That means it is getting close to the 6,500 peak it hit before unravelling across the summer
Remaining near the top of the FTSE 100 charts was British Airways-owner IAG, which surged another 6%, meaning it has moved from £1.05 to 1.48 in the space of 3 sessions.
Nasdaq recovers as Dow lags
Over on Wall Street, the Dow Jones industrial average has dipped in early trading - while tech stocks are making a comeback.
The Dow has dropped by 52 points, or 0.2%, to 29,368.
The Nasdaq, though, has surged by 189 points or 1.6% to 11,743.
As in London, some of the big gainers from earlier this week are dipping back. Financial services firm American Express’s shares are down 4%, while construction equipment maker Caterpillar has dropped 2.5%.
Big Tech is back in vogue, with Salesforce.com gaining 3.5% and Microsoft up 2.6%.
Clearly investors are trying to assess exactly how quickly, and widely, Covid-19 vaccines can be rolled out, and what impact that will have on the global economy.
Richard Flax, chief investment officer at Moneyfarm, says the growth vs value discussion is back.
Remember that in a COVID-19 world, digital businesses rule. They clean up in terms of advertising revenue and sales. Traditional businesses suffer. They have rent, they pump oil, they borrow short and lend long in a world of zero interest rates. And growth stocks crush value stocks, at least in terms of performance.
But in a post-COVID world, where growth begins to recover, alternatives begin to emerge. Digital businesses look expensive. Their multiples are high, their prospects perhaps over-hyped (at times). And then everyone starts thinking about things like mean reversion and hoary old sayings like ‘trees don’t grow to the sky’ (like they said about Amazon in 2014/15/16/17 etc). It probably explains why Zoom fell 17% on Monday.
Goldman Sachs has also predicted the US stock market will climb higher over the next couple of years.
It now estimates the S&P 500 index will end this year at 3,700 points - around 4% higher than currently, up from 3,600 points previously.
And Goldman then sees stocks rising sharply higher next year, and in 2022,
We forecast S&P 500 will climb by 16% to 4300 at year-end 2021 and gain 7% to reach 4600 by the end of 2022.
The market is actually less dependent on the performance of a few mega-cap stocks than many investors perceive.
This forecast is based on the assumption that at least one vaccine is approved by the FDA and administered to a large portion of the US population.
It also assumes that the Republican Party maintains control of the US Senate following run-off elections in Georgia, making it harder for president-elect Biden to push major tax reforms through.
Goldman Sachs’ equity strategist David Kostin explained:
A vaccine is a more important development for the economy and markets than the prospective policies of a Biden presidency. The much-awaited results from Pfizer that its COVID-19 vaccine has an efficacy rate greater than 90% is a positive event that will allow society to gradually normalize during 2021.
Elections have consequences, both for policies and markets. Joe Biden has been elected the 46th President of the United States. However, the upcoming 117th Congress (2021-2023) will likely remain divided but will depend on the results of two run-off Senate elections in Georgia on January 5th. Politics is policy and uncertainty will remain elevated until then. A divided government means little scope for major legislative changes, although trade and regulatory policy stances will likely differ relative to the Trump administration. Unified control would mean more fiscal spending but also higher individual and corporate tax rates.
Updated
Goldman Sachs predicts FTSE 100 will keep rallying
Goldman Sachs analysts have predicted that stocks in London will continue to recover ground over the next year or so, thanks to the encouraging Pfizer vaccine news.
In a research note to clients today, they predict that the FTSE 100 will reach 7200 points by the end of next year.
That’s around 13% higher than today’s levels.
GS believes that economic growth across Europe will pick up strongly in 2021. It will be helped (they predict) by a vaccine rollout, increased fiscal support (government spending) and strong monetary support.
Goldman’s equity strategist Sharon Bell writes:
Our economists expect growth to show a marked acceleration from the end of 1Q as lockdowns ease and populations start to be vaccinated; European and global growth next year should be close to 6%.
The recent positive news on vaccine efficacy from Pfizer supports their view.
And on the London market specifically, they believe it will benefit from a rotation into ‘value’ stocks (where the FTSE is relatively overweight), away from ‘growth’ stocks such as tech firms.
FTSE 100 has underperformed European equities by about 15% YTD, dragged down by its exposure to commodity prices and the underperformance of Value for most of the year.
However, we see the improved macro and commodities environment as supportive going forward, and forecast FTSE 100 to reach 7200 by the end of 2021.
Updated
European markets keep rising as vaccine rally continues
Vaccine optimism is continuing to push European stock markets higher.
The FTSE 100 index is now up 62 points, or 1%, at 6358 -- the highest since June.
The Footsie has now gained over 7% this week, putting it on track for the best weekly performance since April.
Airline group IAG is currently the top risers on the FTSE 100, up 7%.
Other risers include DIY chain Kingfisher (+5.8%) and Ocado (+4.8%). Their shares had fallen earlier this week as investors piled into beaten-up airlines, hospitality companies, and banks, but are now back in favour.
Other European markets are showing gains, keeping the Stoxx 600 index at an eight-month high.
- Germany’s DAX: up 58 points or 0.45% at 13,221
- France’s CAC: up 28 points or 0.6% at 5448
- Italy’s FTSE MIB: up 181 points or 0.8% at 21,033
- Spanish IBEX: up 73 points, or 0.95%, at 7,784
Pfizer’s vaccine will be logistically complicated to roll out, not least because it needs to be kept extremely cold. But Joshua Mahony, Senior Market Analyst at IG, says the encouraging Pfizer/BioNTech results are boosting hopes for other vaccines too
“With the UK expected to begin administering the Pfizer vaccine in just a months’ time, there is a feeling that this could move particularly quickly once a vaccine has been approved.
Over in America, the number of weekly mortgage applications has fallen back.
Mortgage applications decreased 0.5% week-on-week in the seven days to Friday 6th, according to data from the Mortgage Bankers Association.
In the previous week, mortgage applications jumped by 3.8%, so this is quite a reversal [although these weekly figures can be erratic, and potential housebuyers may have been distracted by the election].
It could remind US politicians of the need for a new stimulus package, with economists concerned that its economy is slowing.
Back in Europe, the pound has briefly nudged a six-month high against the euro.
Sterling traded as high as €1.1284, the highest since May, before dropping back towards its earlier two-month high.
Reuters reports that vaccine optimism is giving the pound a lift:
The pound benefited as investors judged that a vaccine would be a particular boon to the UK, which has seen its economy ravaged by the coronavirus.
“Since Britain has been disproportionately hit by the virus, it will be disproportionately helped by a vaccine,” wrote Marshall Gittler, head of investment research at BDSwiss Group.
The euro has also lost ground against the US dollar today, down nearly half a cent.
Kit Juckes, foreign exchange expert at Société Générale, points out:
In FX, this week’s wining currencies come from countries which might have been thinking about negative rates but haven’t yet done the deed, and the losers are the ones which already have negative rates.
The yen, Swiss franc and euro are all lower against the dollar since the vaccine news emerged.
But, of course, the Brexit negotiations will also influence both currencies.
Daniel Boffey, our Brussels bureau chief, reports that a video conference summit of EU leaders on 19 November is now viewed by Brussels as the final deadline for a draft Brexit deal, with negotiations continuing...
The thorniest problems to resolve remain the level of access to UK waters provided to EU fishing fleets, how to maintain fair competition rules for business – including rules on domestic subsidies – and the mechanism in the final treaty for resolving future disputes.
Chinese tech stocks closed sharply lower
China’s technology giants ended the day deep in the red, following Beijing’s proposed clampdown on anticompetitive conduct.
Alibaba led the fallers, along with fellow e-commerce giant JD.com, tech conglomerate Tencent, and shopping platform and food delivery service Meituan. Electronics manufacturer Xiaomi also dropped sharply, as tech stocks fell further out of favour.
- Alibaba: -9.80%
- Tencent Holdings: -7.4%
- JD.com: -9.2%
- Meituan: -9.6%
- Xiaomi: -8.2%
As explained earlier, the new rules would rein in a range of behaviour, by:
- attempting to stop companies sharing sensitive consumer data, forming alliances to hurt smaller rivals, or subsidising services below cost price to eliminate competitors.
- clamping down on platforms forcing businesses into exclusivity arrangements
- preventing companies treating customers differently based on their data and spending habits.
Bloomberg has more details:
The Hang Seng Tech Index slumped more than 6% on Wednesday in Hong Kong, taking its two-day loss to 11%. Shares in the quintet of firms have sunk at least 11% over two sessions.
Bloomberg: Alibaba Leads Chinese Internet Selloff Nearing $290 Billion
Concerns about China has also helped prompt the British government to draw up new proposed powers to block takeovers and corporate deals that threaten national security.
The National Security and Investment Bill, published this morning, will give ministers greater powers to scrutinise takeover activity in key sectors such as energy and defence.
Business Secretary Alok Sharma has said the proposed legislation will stop ‘hostile actors’ from threatening the public’s safety.
“The UK remains one of the most attractive investment destinations in the world and we want to keep it that way.
“But hostile actors should be in no doubt - there is no back door into the UK.”.
Our defence and security editor, Dan Sabbagh, explains:
Ministers and officials have been careful to draw up the legislation in a country-neutral manner, but although there are concerns about Russian companies, it is takeovers involving Chinese firms that will come under the greatest scrutiny.
The proposals emerge at a time of heightened political concern about Chinese ownership in key parts of the economy, while the coronavirus pandemic has also further revealed dependencies on foreign suppliers for critical goods.
A growing number of Conservative backbenchers also want to make it harder for Chinese companies to buy strategic British firms – after they successfully forced the government to drop Huawei from 5G mobile networks after 2027.
One of the party’s MPs, Bob Seely, said he welcomed the intent of the bill but wanted ministers to be clear about how far takeovers by foreign companies could be blocked amid concerns over human rights.
More here:
European stock markets have also extended their gains this morning, with France’s CAC and Germany’s DAX both up around 0.4%.
This has pushed the Stoxx 600 index to a fresh eight-month high, clawing back more of its losses since the pandemic began.
Geoff Yu, senior market strategist at BNY Mellon, says:
This week’s momentous news of a potentially successful vaccine for COVID-19 has triggered one of the biggest rotations in asset markets in recent memory.
Unsurprisingly, the eurozone equities market has been a major beneficiary as its value heavy components finally found favor.
Yu adds that the eurozone should benefit from more fiscal support next year, while US politicians have so far failed to agree a new Covid-19 stimulus package.
While Senate Majority Leader Mitch McConnell saw the vaccine news as an opening to reduce the amount of stimulus which could be deployed, the eurozone has just overcome certain political hurdles to agree the Next Generation EU rescue fund and a multi-year budget to start deployment as soon as mid-next year.
The oil price is higher again this morning too, with Brent crude gaining 3% to $45 per barrel.
That’s its highest level since 2nd September, up from below $38 at the end of October.
Overnight, the American Petroleum Institute reported a larger drop in reserves than expected, suggesting a pick-up in demand for oil and gasoline.
Ongoing vaccine optimism is also lifting oil, as Marios Hadjikyriacos of XM explains:
Crude oil continues its relentless rally, the exodus from tech stocks is in full swing, and sovereign bond yields are marching higher, keeping the broader stock market on a tight leash.
Speaking of Rolls-Royce... it is also pledging to create 6,000 UK jobs within five years if the government backs its plans to build small nuclear reactors around the country.
The idea is to create most of the components at factories across the Midlands and the north of England, so they can be moved to existing nuclear sites around the country to be assembled.
My colleague Jasper Jolly explains:
The engineering company is part of a consortium that is pushing for the government to commit billions of pounds to build 16 of the small modular reactors (SMRs) around the UK.
The factory-built nuclear power stations are predicted to provide up to 440MW of electricity, enough to power a city of 450,000 homes for 60 years...
Small nuclear reactors were first developed in the 1950s to use in nuclear-powered submarines. Since then Rolls-Royce has designed reactors for seven classes of submarine and two separate land-based prototype reactors.
FTSE 100 opens higher
Meanwhile in London, the stock market has continued its recent strong rally.
The FTSE 100 index of blue-chip shares is currently up 32 points, or 0.5%, at 6328 points - back at levels last seen in June.
But, some of the stocks which surged this week on Covid-19 vaccine optimism are dipping. Rolls-Royce is down over 4%, catering group Compass has lost 3.6%, and hotel chain InterContinental has dropped 3.1%.
Ocado, which fell sharply earlier this week, is now up 3.6%, with DIY chain Kingfisher gaining 3.8% and pharmaceuticals group Hikma also in the risers (+2.8%).
This suggests that the rotation out of companies who did well in the pandemic, and into those who will benefit most from a Covid-1 vaccine, is taking a breather.
Neil Wilson of Markets.com explains:
Rotation is not going to be a straight line – this reopening move is taking a bit of a hit this morning. After the initial kneejerk, investors will need to work out now which ‘value’ stocks remain value traps and which have some growth in them.
Expect pullbacks along the way but the overall landscape remains much more positive than it was a week ago for these sectors worst affected by the pandemic.
Updated
Analyst: End of an era for China web firms
China’s new antitrust regulations are a first major step towards curbing its tech giants, points out the The Financial Times:
Until now, Chinese regulators have taken a relatively hands-off approach to antitrust, even as authorities in the US and Europe launched inquiries and investigations into Amazon, Facebook, Google and others.
This is in spite of the fact that Chinese tech companies have been building increasingly captive ecosystems, with users being prevented from using WeChat Pay to purchase products in Alibaba’s Taobao online store, for instance, or easily sharing links to Taobao goods within WeChat.
The new guidelines mark the first time the State Administration for Market Regulation has directly tackled anti-competitive behaviour in the internet sector.
“It signals the end of an era — it will fundamentally change the competition landscape in China for internet companies,” said Scott Yu, an antitrust expert at Zhonglun Law Firm.
Bloomberg has calculated that more than $200bn has been wiped off China’s tech giants in the last two days.
They report that the antitrust clampdown triggered a wave of selling (just a day after vaccine optimism triggered a rotation out of tech stocks):
Chinese technology giants from Alibaba Group Holding Ltd. to Tencent Holdings Ltd shed almost $260 billion of market value over two days of frantic selling, as investors scrambled to assess the fallout from Beijing’s broadest attempt to rein in its most powerful private-sector firms.
Technology shares tumbled for a second day after Beijing issued regulations designed to curb the growing influence of internet-sector leaders including JD.com Inc., Meituan and Xiaomi Corp.
The Hang Seng Tech Index slumped 5.6% on Wednesday in Hong Kong, taking its two-day loss to 10% as of midday. Shares in the quintet of firms have sunk at least 8% over two sessions.
Updated
Introduction: China cracks down on internet giants
Good morning, and welcome to our rolling coverage of the world economy, the financial markets, the eurozone and business.
Shares in China’s technology industry have taken a tumble after Beijing’s market regulator took its first major step towards tackling the monopolistic power of its tech giants.
The State Administration for Market Regulation’s new draft rules will, for the first time, defines what constitutes anti-competitive behaviour -- covering pricing, payment methods, and the use of data to target shoppers.
These proposed anti-monopoly rules are designed to ensure fair competition in the web space, and prevent internet platforms from dominating the market or using methods to blocking fair competition.
The move seems certain to put e-commerce marketplaces and payment services under closer scrutiny... and investor have reacted by ditching tech shares sharply.
E-commerce giant Alibaba’s shares, for example, have slumped by 9% today, while rival JD.com is down over 8%.
The news came China’s web giants were gearing up for Singles Day, the annual online sale which is their biggest day of the year.
Reuters explains:
The draft rules would also consider whether a transaction treats different customers in different ways based on big data, payment ability, consumption preferences, and usage habits.
The draft rules issued on Tuesday would look to prevent e-commerce practices such as “choose one between two”, under which an e-commerce marketplace restricts brands from selling on multiple platforms.
This news, a week after Beijing forced Alibaba to suspend floating its Ant Group on the stock markets, suggests China’s technology sector may be entering a new era of closer control.
More details and reaction to follow....
The agenda
- 12pm GMT: US weekly mortgage applications
- 1pm GMT: ECB president Christine Lagarde speaks at an online forum on Central Banking
Updated